| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	Psychedelics-focused mental health care company Numinus Wellness Inc. (TSXV: NUMI) (OTCQX: NUMIF) announced its fiscal fourth q...
 
																	The Week In Psychedelics Seattle Decriminalizes Psychedelics Along With California City
 
																	The Week In Psychedelics:
 
																	Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mesc...
 
																	Psychedelics ETFs Are Gaining Traction Defiance ETFs launched the “Next Gen Altered Experience ETF,” the first U.S.-listed ETF...
 
																	PharmaDrug Inc. (CSE: BUZZ) (Pink: LMLLF) announced an FDA-granted Orphan Drug Designation to its wholly owned subsidiary Sairi...
 
																	Numinus Wellness (Pink: LKYSF) (TSXV: NUMI) announced the launch of a new clinical trial that will add information to an indust...
 
																	Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week
 
																	These days, the psychedelics finds itself in the midst of a public debate around the moral implications of patents and intellec...